88 related articles for article (PubMed ID: 17869233)
1. Plasma chitotriosidase in lysosomal storage diseases.
Isman F; Hobert JA; Thompson JN; Natowicz MR
Clin Chim Acta; 2008 Jan; 387(1-2):165-7. PubMed ID: 17869233
[No Abstract] [Full Text] [Related]
2. Elevated plasma chitotriosidase activity in various lysosomal storage disorders.
Guo Y; He W; Boer AM; Wevers RA; de Bruijn AM; Groener JE; Hollak CE; Aerts JM; Galjaard H; van Diggelen OP
J Inherit Metab Dis; 1995; 18(6):717-22. PubMed ID: 8750610
[TBL] [Abstract][Full Text] [Related]
3. Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch.
Auwerda JJ; Leebeek FW; Wilson JH; van Diggelen OP; Lam KH; Sonneveld P
Transfusion; 2006 Oct; 46(10):1705-11. PubMed ID: 17002626
[TBL] [Abstract][Full Text] [Related]
4. Human chitotriosidase: a potential new marker of sarcoidosis severity.
Bargagli E; Maggiorelli C; Rottoli P
Respiration; 2008; 76(2):234-8. PubMed ID: 18487875
[TBL] [Abstract][Full Text] [Related]
5. Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases.
Civallero G; Michelin K; de Mari J; Viapiana M; Burin M; Coelho JC; Giugliani R
Clin Chim Acta; 2006 Oct; 372(1-2):98-102. PubMed ID: 16712827
[TBL] [Abstract][Full Text] [Related]
6. Chitotriosidase in neonates with fungal and bacterial infections.
Labadaridis I; Dimitriou E; Theodorakis M; Kafalidis G; Velegraki A; Michelakakis H
Arch Dis Child Fetal Neonatal Ed; 2005 Nov; 90(6):F531-2. PubMed ID: 16244214
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease.
Wajner A; Michelin K; Burin MG; Pires RF; Pereira ML; Giugliani R; Coelho JC
Clin Biochem; 2007 Mar; 40(5-6):365-9. PubMed ID: 17291472
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.
Aerts JM; van Breemen MJ; Bussink AP; Ghauharali K; Sprenger R; Boot RG; Groener JE; Hollak CE; Maas M; Smit S; Hoefsloot HC; Smilde AK; Vissers JP; de Jong S; Speijer D; de Koster CG
Acta Paediatr; 2008 Apr; 97(457):7-14. PubMed ID: 18339181
[TBL] [Abstract][Full Text] [Related]
9. Plasma chitotriosidase activity in children with lysosomal storage disorders.
Sheth JJ; Sheth FJ; Oza NJ; Gambhir PS; Dave UP; Shah RC
Indian J Pediatr; 2010 Feb; 77(2):203-5. PubMed ID: 19936666
[TBL] [Abstract][Full Text] [Related]
10. Chitotriosidase activity in sarcoidosis and some other pulmonary diseases.
Tercelj M; Salobir B; Simcic S; Wraber B; Zupancic M; Rylander R
Scand J Clin Lab Invest; 2009; 69(5):575-8. PubMed ID: 19347743
[TBL] [Abstract][Full Text] [Related]
11. Micromethod for the fluorimetric determination of plasma N-acetyl-alpha-D-galactosaminidase and study of some of its characteristics.
Den Tandt WR; Scharpé S
Enzyme Protein; 1996; 49(5-6):273-80. PubMed ID: 9252785
[TBL] [Abstract][Full Text] [Related]
12. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
[TBL] [Abstract][Full Text] [Related]
13. Neonatal chitotriosidase activity is not predictive for Niemann-Pick disease type A/B: implications for newborn screening for lysosomal storage disorders.
Porta F; Pagliardini V; Barbera C; Calvo P; Pagliardini S; Lualdi S; Filocamo M; Spada M
Mol Genet Metab; 2013 Jan; 108(1):106. PubMed ID: 23228552
[No Abstract] [Full Text] [Related]
14. Blood spot versus plasma chitotriosidase: a systematic clinical comparison.
Elmonem MA; Ramadan DI; Issac MS; Selim LA; Elkateb SM
Clin Biochem; 2014 Jan; 47(1-2):38-43. PubMed ID: 24177195
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal storage diseases as differential diagnoses to rheumatic disorders.
Michels H; Mengel E
Curr Opin Rheumatol; 2008 Jan; 20(1):76-81. PubMed ID: 18281861
[TBL] [Abstract][Full Text] [Related]
16. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity.
Bargagli E; Bianchi N; Margollicci M; Olivieri C; Luddi A; Coviello G; Grosso S; Rottoli P
Scand J Clin Lab Invest; 2008; 68(6):479-83. PubMed ID: 18609101
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal storage diseases market.
Werber Y
Nat Rev Drug Discov; 2004 Jan; 3(1):9-10. PubMed ID: 14756143
[No Abstract] [Full Text] [Related]
18. Plasma chitotriosidase activity and malaria.
Chien YH; Chen JH; Hwu WL
Clin Chim Acta; 2005 Mar; 353(1-2):215; author reply 217. PubMed ID: 15698611
[No Abstract] [Full Text] [Related]
19. [Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report)].
Gołab K; Passowicz-Muszyńska E; Jankowska R; Warwas M
Pol Merkur Lekarski; 2009 Mar; 26(153):194-7. PubMed ID: 19388531
[TBL] [Abstract][Full Text] [Related]
20. Optical detection of plasma chitotriosidase activity in healthy Chinese children using fluorescence spectrophotometry.
Cai CL; Zhou X; Zhao L; Yao XJ; Tu JC; Zheng F; Qu XY
Clin Chim Acta; 2007 Apr; 379(1-2):134-8. PubMed ID: 17300771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
